The Predictive Value of Neutrophil-To-Lymphocyte Ratio (NLR) for Response to Neoadjuvant Immunochemotherapy in Resectable IIA-IIIB Non-Small Cell Lung Cancer in Real-World Practice.

Thorac Cancer · 2026 · PMC13328838 · PMID 42394173

Europe PMC DOI

hedged sentence

0.0730

closest p · 1.5× alpha

0.0730

boldest claim

The sentences

a strong trendp = 0.073so close (0.05 < p ≤ 0.1)

38.5%, p = 0.008), and a strong trend toward improved pCR was observed (34.0% vs. 21.8%, p = 0.073).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.